Similares a Pegtarazimod Cuts Oxygen Need in Hospitalized COPD Patients | ATS 2026 | Gerald Criner, MD

20 vecinos (text_768) · 29 views · HCPLive · Estados Unidos


★	Pegtarazimod Cuts Oxygen Need in Hospitalized COPD Patients \| ATS 2026 \| Gerald Criner, MD	HCPLive @hcplivenews	29	Estados Unidos
20	Idiopathic Pulmonary Fibrosis - Treatment and New Hope	MedCram - Medical Lectures Explained CLEARLY @medcram	9.0K	Estados Unidos	84
2	Mepolizumab Add-On Reduces COPD Exacerbations in Triple-Therapy Patients \| ATS 2026	HCPLive @hcplivenews	1.2K	Estados Unidos	88
17	Diabetes Dialogue: FDA Approves Afrezza Inhaled Insulin for Pediatric Patients	HCPLive @hcplivenews	683	Estados Unidos	84
11	Efdoralprin Alfa Normalizes Alpha-1 Antitrypsin Levels I #ats2026	HCPLive @hcplivenews	548	Estados Unidos	85
12	Inhaled Treprostinil for IPF: TETON-1 Phase 3 Results With Steven Nathan, MD \| ATS 2026	HCPLive @hcplivenews	301	Estados Unidos	85
15	Avances terapéuticos en Hipertensión Pulmonar y su impacto en pacientes con comorbilidades	FAC @fac_cardio	209	Argentina	84
5	Mixed AERIFY Data May Delay Itepekimab Approval Pathway in COPD, With Klaus F. Rabe, MD, PhD	HCPLive @hcplivenews	198	Estados Unidos	86
18	Respiratory & Other Systems Pharmacology \| Section 5 – Brenner & Stevens’ Pharmacology (6th)	Last Minute Lecture @lastminutelecture	193	Estados Unidos	84
9	Efdoralprin Alfa vs Standard of Care in AATD: Phase 2 ElevAATe Results	HCPLive @hcplivenews	156	Estados Unidos	85
14	Tezepelumab Reduced Severe Asthma Exacerbations Across Phenotypes \| ATS 2026	HCPLive @hcplivenews	122	Estados Unidos	85
16	Phase 3b ENCORE: ALIS Improves MAC Lung Disease Outcomes \| ATS 2026	HCPLive @hcplivenews	117	Estados Unidos	84
1	Mepolizumab Reduced COPD Hospitalizations in Eosinophilic Disease \| ATS 2026 With Gerard Criner, MD	HCPLive @hcplivenews	113	Estados Unidos	90
13	Sotatercept May Improve RV Function in Group 3 3 Pulmonary Hypertension	HCPLive @hcplivenews	112	Estados Unidos	85
4	AERIFY: Phase 3 Data Reveal Challenges, Potential of Itepekimab in COPD	HCPLive @hcplivenews	105	Estados Unidos	86
8	Efdoralprin Alfa vs Standard of Care in AATD: Phase 2 ElevAATe Results	HCPLive @hcplivenews	82	Estados Unidos	85
7	Tezepelumab Cuts Severe Asthma Exacerbations 70% in Real-World Patients \| ATS 2026	HCPLive @hcplivenews	68	Estados Unidos	85
6	ATS 2026 Pulmonology: AD109, Ralinepag, ALIS, Itepekimab & More \| HCPLive Expert Interviews	HCPLive @hcplivenews	55	Estados Unidos	85
19	Respiratory Disorder Drug Therapy \| Chapter 27 – Brenner & Stevens’ Pharmacology (6th)	Last Minute Lecture @lastminutelecture	52	Estados Unidos	84
3	SGLT2 Inhibitors May Reduce COPD Readmissions I ATS 2026	HCPLive @hcplivenews	48	Estados Unidos	88
10	Helping Patients Breathe Easier \| Lynn Bingaman, CRNP at Geisinger	Geisinger @geisingerhealth	45	Estados Unidos	85